
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | Alcon Research | N-207926 RX | 2015-01-15 | 2 products, RLD |
| BIORPHEN | Dr Reddys Laboratories | N-212909 RX | 2019-10-21 | 1 products, RLD, RS |
| PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Dr Reddys Laboratories | N-216830 RX | 2025-05-30 | 1 products, RLD, RS |
| PHENYLEPHRINE HYDROCHLORIDE | Hikma Pharmaceuticals | N-203826 RX | 2012-12-20 | 3 products, RLD, RS |
| IMMPHENTIV | Hikma Pharmaceuticals | N-203826 RX | 2023-03-09 | 2 products, RLD, RS |
| PHENYLEPHRINE HYDROCHLORIDE | Paragon BioTeck | N-203510 RX | 2013-03-21 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OMIDRIA | Rayner Surgical | N-205388 RX | 2014-05-30 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MYDCOMBI | Hyperion DeFi | N-215352 DISCN | 2023-05-05 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN VC | ANI Pharmaceuticals | N-008604 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN VC W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| biorphen | New Drug Application | 2024-04-25 |
| cyclomydril | ANDA | 2025-05-15 |
| dextromethorphan hydrobromide and promethazine hydrochloride | ANDA | 2024-06-05 |
| immphentiv phenylephrine hydrochloride | New Drug Application | 2024-04-09 |
| mydcombi | New Drug Application | 2023-05-09 |
| omidria | New Drug Application | 2023-07-07 |
| phenadoz | ANDA | 2021-03-01 |
| phenergan | ANDA | 2024-08-09 |
| phenylephrine hydrochloride | New Drug Application | 2020-03-10 |
| prometh with codeine | ANDA | 2012-01-24 |
Expiration | Code | ||
|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE / TROPICAMIDE, MYDCOMBI, EYENOVIA | |||
| 2026-05-05 | NP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Phenylephrine Hydrochloride, Immphentiv, Hikma | |||
| 11213480 | 2036-09-26 | DP | |
| 11471400 | 2036-08-05 | DP | |
| Phenylephrine Hydrochloride, Phenylephrine Hydrochloride, Paragon Bioteck | |||
| 8859623 | 2033-11-14 | U-1594 | |
| Ketorolac Tromethamine / Phenylephrine Hydrochloride, Omidria, Rayner Surgical | |||
| 9066856 | 2033-10-23 | DP | |
| 9486406 | 2033-10-23 | DP | |
| 9855246 | 2033-10-23 | DP | |
| Phenylephrine Hydrochloride / Tropicamide, Mydcombi, Eyenovia | |||
| 10839960 | 2031-07-15 | U-3685 | |
| 11398306 | 2031-07-15 | U-3685 | |
| 11839487 | 2031-07-15 | U-3685 | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 133 | 1 | — | 2 | 10 | 145 |
| Hypotension | D007022 | EFO_0005251 | I95 | 5 | 8 | 7 | 25 | 38 | 79 |
| Asthma | D001249 | EFO_0000270 | J45 | 16 | 8 | 2 | 1 | 1 | 28 |
| Mydriasis | D015878 | — | H57.04 | 2 | 2 | 5 | 9 | 6 | 23 |
| Anesthesia | D000758 | — | — | 1 | 4 | 4 | 7 | 7 | 23 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 9 | 6 | 4 | 1 | 1 | 21 |
| Spinal anesthesia | D000775 | — | — | — | 2 | 1 | 8 | 6 | 17 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | 5 | 6 | 2 | 3 | 17 |
| Cataract | D002386 | EFO_0001059 | H26.9 | 2 | 1 | 4 | 5 | 6 | 17 |
| Cesarean section | D002585 | — | — | — | — | — | 5 | 9 | 14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Syndrome | D013577 | — | — | — | — | 1 | — | 7 | 8 |
| Nasal obstruction | D015508 | — | — | 2 | 2 | 2 | — | 1 | 7 |
| Obstructive lung diseases | D008173 | — | — | 1 | — | 3 | — | 1 | 5 |
| Heart failure | D006333 | EFO_0003144 | I50 | 2 | — | 1 | — | 2 | 5 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | 1 | — | 4 | 5 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | 2 | 1 | — | 2 | 4 |
| Cold temperature | D003080 | — | — | — | — | 3 | — | — | 3 |
| Infections | D007239 | EFO_0000544 | — | — | — | 3 | — | — | 3 |
| Intraocular lens implantation | D019654 | — | — | — | — | 3 | — | — | 3 |
| Eye diseases | D005128 | EFO_0003966 | H44 | — | — | 2 | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Parkinson disease | D010300 | EFO_0002508 | G20 | 6 | 2 | — | — | 1 | 9 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 2 | 1 | — | — | 2 | 5 |
| Fasting | D005215 | EFO_0002756 | — | 2 | 1 | — | — | — | 3 |
| Dental caries | D003731 | EFO_0003819 | K02 | — | 3 | — | — | — | 3 |
| Periapical periodontitis | D010485 | EFO_1001391 | K04.5 | — | 3 | — | — | — | 3 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 1 | — | — | 1 | 2 |
| Traumatic stress disorders | D040921 | — | — | — | 1 | — | — | 1 | 2 |
| Microcirculation | D008833 | — | — | — | 1 | — | — | 1 | 2 |
| Hypertriglyceridemia | D015228 | EFO_0004211 | — | 1 | 1 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 3 | — | — | — | 8 | 11 |
| Therapeutic equivalency | D013810 | — | — | 9 | — | — | — | — | 9 |
| Pharmacokinetics | D010599 | — | — | 8 | — | — | — | — | 8 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 4 | — | — | — | 2 | 6 |
| Biological availability | D001682 | — | — | 5 | — | — | — | — | 5 |
| Hypoxia | D000860 | — | R09.02 | 1 | — | — | — | 4 | 5 |
| Orthostatic hypotension | D007024 | — | I95.1 | 2 | — | — | — | 2 | 4 |
| Postural orthostatic tachycardia syndrome | D054972 | — | G90.A | 1 | — | — | — | 3 | 4 |
| Essential hypertension | D000075222 | — | I10 | 3 | — | — | — | — | 3 |
| Surgical blood loss | D016063 | — | — | 1 | — | — | — | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carotid endarterectomy | D016894 | — | — | — | — | — | — | 4 | 4 |
| Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 3 | 3 |
| Autonomic dysreflexia | D020211 | EFO_1001762 | G90.4 | — | — | — | — | 3 | 3 |
| Brain injuries | D001930 | — | S06.9 | — | — | — | — | 2 | 2 |
| Aging | D000375 | GO_0007568 | R41.81 | — | — | — | — | 2 | 2 |
| Delirium | D003693 | — | R41.0 | — | — | — | — | 2 | 2 |
| Blood circulation | D001775 | — | — | — | — | — | — | 2 | 2 |
| Nausea | D009325 | — | R11.0 | — | — | — | — | 2 | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 2 | 2 |
| Femoral fractures | D005264 | — | S72 | — | — | — | — | 2 | 2 |
| Drug common name | Phenylephrine |
| INN | phenylephrine |
| Description | Phenylephrine is a member of the class of the class of phenylethanolamines that is (1R)-2-(methylamino)-1-phenylethan-1-ol carrying an additional hydroxy substituent at position 3 on the phenyl ring. It has a role as an alpha-adrenergic agonist, a cardiotonic drug, a mydriatic agent, a protective agent, a vasoconstrictor agent, a sympathomimetic agent and a nasal decongestant. It is a member of phenylethanolamines, a secondary amino compound and a member of phenols. It is a conjugate base of a phenylephrine(1+). |
| Classification | Small molecule |
| Drug class | α1-adrenergic receptor agonist; vasopressor |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CNC[C@H](O)c1cccc(O)c1 |
| PDB | — |
| CAS-ID | 59-42-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1215 |
| ChEBI ID | 8093 |
| PubChem CID | 6041 |
| DrugBank | DB00388 |
| UNII ID | 1WS297W6MV (ChemIDplus, GSRS) |































































































































































































































